Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT

Bone Marrow Transplantation

Volumn 47, Issue 9, 2012, Pages 1201-1205

  Mo, X D ^a   Xu, L P ^a   Liu, D H ^a   Chen, Y H ^a   Han, W ^a   Zhang, X H ^a   Chen, H ^a   Wang, Y ^a   Wang, J Z ^a   Liu, K Y ^a   Huang, X J ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

allogeneic hematopoietic SCT; chronic GVHD; health related quality of life; HLA haploidentical; partially matched related donor

Indexed keywords

ACUTE LEUKEMIA; ADULT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; DONOR SELECTION; EMOTIONAL STABILITY; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HAPLOTYPE; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; SCORING SYSTEM; SEX DIFFERENCE; SHORT FORM 36; SOCIAL INTERACTION; WORK RESUMPTION;

ADULT; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; LEUKEMIA, BASOPHILIC, ACUTE; MALE; MYELODYSPLASTIC SYNDROMES; QUALITY OF LIFE; SIBLINGS; TISSUE DONORS; TRANSPLANTATION CONDITIONING;

EID: 84865990224     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.250     Document Type: Article

References (29)

1. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W et al. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 2006; 38: 291-297. (Pubitemid 44203779)
2. Han W, Lu DP, Huang XJ, Liu KY, Chen H, Xu LP et al. Mismatched hematopoietic stem cell transplantation using GIAC protocol: report of 100 cases. Zhonghua Xue Ye Xue Za Zhi 2004; 25: 453-457.
3. Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 2004; 104: 1898-1906. (Pubitemid 39202304)
4. Wong FL, Francisco L, Togawa K, Bosworth A, Gonzales M, Hanby C et al. Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns. Blood 2010; 115: 2508-2519.
5. Fraser CJ, Bhatia S, Ness K, Carter A, Francisco L, Arora M et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 2006; 108: 2867-2873.
6. Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW et al. Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment. Ann Hematol 1998; 77: 27-32. (Pubitemid 28425171)
7. Sutherland HJ, Fyles GM, Adams G, Hao Y, Lipton JH, Minden MD et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1997; 19: 1129-1136. (Pubitemid 27267738)
8. Duell T, van Lint MT, Ljungman P, Tichelli A, Socié G, Apperley JF et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997; 126: 184-192.
9. Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004; 291: 2335-2343. (Pubitemid 38656300)
10. Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM. Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant 2000; 6: 576-591.
11. Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000; 110: 614-619.
12. Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 2008; 42: 819-827.
13. Bush NE, Haberman M, Donaldson G, Sullivan KM. Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Soc Sci Med 1995; 40: 479-490.
14. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
15. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-276. (Pubitemid 11174888)
16. Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995; 33(suppl): AS264-AS279.
17. Li L, Wang HM, Shen Y. Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health 2003; 57: 259-263. (Pubitemid 36399113)
18. Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 619-626. (Pubitemid 35414812)
19. Sanders JE, Hoffmeister PA, Storer BE, Appelbaum FR, Storb RF, Syrjala KL. The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplant 2010; 45: 746-754.
20. Higman MA, Vogelsang GB. Chronic graft versus host disease. Br J Haematol 2004; 125: 435-454. (Pubitemid 38916189)
21. Teshima T, Matsuo K, Matsue K, Kawano F, Taniguchi S, Hara M et al. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors. Br J Haematol 2005; 130: 575-587. (Pubitemid 43899762)
22. Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/ haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006; 107: 3065-3073.
23. Chen XH, Gao L, Zhang X, Gao L, Zhang C, Kong PY et al. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation. Blood Cell Mol Dis 2009; 43: 98-104.
24. Basara N, Baurmann H, Kolbe K, Yaman A, Labopin M, Burchardt A et al. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transplant 2005; 35: 1011-1018. (Pubitemid 40711839)
25. Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant 2006; 12: 560-565. (Pubitemid 43956361)
26. Bacigalupo A, Lamparelli T, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 2001; 98: 2942-2947.
27. Temple RO, Carvalho J, Tremont G. A national survey of physicians' use of and satisfaction with neuropsychological services. Arch Clin Neuropsychol 2006; 21: 371-382. (Pubitemid 44247517)
28. Paller AS, McAlister RO, Doyle JJ, Jackson A. Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment. Clin Pediatr (Phila) 2002; 41: 323-332. (Pubitemid 34633835)
29. Byrne NM, Hardy L. Community physiotherapy for children with cystic fibrosis: a family satisfaction survey. J Cyst Fibros 2005; 4: 123-127. (Pubitemid 40867762)